securities fraud

Kyndryl faces class action lawsuit alleging material misrepresentations about financial condition and internal controls. Stock fell 55% after disclosures of control weaknesses and executive departures.

Rosen Law Firm sues Franklin BSP Realty Trust for allegedly misleading investors about dividend sustainability. Lead plaintiff deadline set for April 27, 2026.

Rosen Law Firm filed securities class action against Oracle, alleging materially false statements about AI infrastructure strategy and undisclosed capital expenditures. Affected investors urged to consult legal counsel before deadline.

Rosen Law Firm sues Corcept Therapeutics for allegedly making misleading statements about clinical trial data and FDA approval prospects for its relacorilant drug candidate.

Rosen Law Firm investigates GSI Technology for allegedly misrepresenting chip capabilities for AI workloads, triggering 14.2% stock decline and potential class action lawsuit.

Rosen Law Firm investigates Vital Farms for alleged disclosure violations after stock plunged 10.8% following disappointing earnings report.

BellRing Brands faces securities lawsuit alleging executives misrepresented 2025 sales drivers, attributing growth to retail inventory builds rather than consumer demand. Stock fell 33% after retailers reduced excess inventory.

Securities fraud lawsuits filed against four public companies for alleged false statements. Investors must file lead plaintiff motions by April 3-6, 2026, to participate.

Kyndryl faces securities fraud lawsuit after CFO and General Counsel departed, triggering 54.9% stock drop. SEC investigating cash management and internal control weaknesses.

Corcept Therapeutics faces securities lawsuit alleging misrepresentation of relacorilant clinical data and FDA approval prospects, while withholding known regulatory risks from investors.

Class action lawsuit filed against agilon health for allegedly making false statements about 2026 financial guidance and misrepresenting risk reduction initiatives' financial impact.

Varonis Systems faces class action lawsuit for allegedly making false statements about SaaS conversion capabilities, causing inflated stock prices during February-October 2025.

Class action lawsuit filed against Snowflake for allegedly making misleading statements about business impact while concealing product efficiency changes and pricing adjustments between June 2023 and February 2024.

NuScale Power faces securities fraud lawsuit over failing to disclose risks associated with a $495 million ENTRA1 deal. Stock fell 12.4% after November disclosure.

SDM investors can join securities fraud class action alleging market manipulation through social media misinformation. Deadline to submit lead plaintiff motions is March 16, 2026.

Ramaco Resources faces class action lawsuit alleging executives made false statements about Brook Mine operations, claiming mining activity had commenced when it hadn't.

Class action lawsuit filed against Franklin BSP Realty Trust alleging false statements about dividend sustainability. Covers investors who purchased shares November 2024-February 2026.

Portnoy Law Firm sues Corcept Therapeutics over alleged misrepresentations about drug candidate relacorilant, following FDA rejection that caused stock to plummet 50%.

LAKE faces securities class action for alleged misstatements about operational performance and tariff strategies. Investors have until April 24, 2026 deadline to join.

Class action lawsuits filed against PayPal for misleading revenue projections and REGENXBIO for concealing gene therapy safety concerns, both triggering significant stock declines.